-
1Academic Journal
Συγγραφείς: A. G. Kupriyanova, L. V. Beletskaya, V. A. Zaidenov, I. M. Iljinsky, N. P. Mogeiko, Z. V. Tatievskaya, D. V. Shumakov, А. Г. Куприянова, Л. В. Белецкая, В. А. Зайденов, И. М. Ильинский, Н. П. Можейко, З. В. Татиевская, Д. В. Шумаков
Πηγή: Russian Journal of Transplantology and Artificial Organs; Том 13, № 2 (2011); 70-77 ; Вестник трансплантологии и искусственных органов; Том 13, № 2 (2011); 70-77 ; 1995-1191 ; 10.15825/1995-1191-2011-2
Θεματικοί όροι: иммунофлюоресценция, accelerated humoral rejection, antibody-mediated rejection, immunofluorescence, ускоренное гуморальное отторжение, антитело- обусловленное отторжение
Περιγραφή αρχείου: application/pdf
Relation: https://journal.transpl.ru/vtio/article/view/377/318; Куприянова А.Г., Белецкая Л.В., Зайденов В.А. и др. Опыт использования иммуногистохимического метода исследования эндомиокардиальных биопсий в диагностике отторжения гуморального типа у больных с аллотрансплантатом сердца // Вестник транс- плантологии и искусственных органов. 2009. Т. XI. No 3. С. 30–36.; Куприянова А.Г., Белецкая Л.В. Антителоопосредо- ванное (гуморальное) отторжение аллотранспланта- та сердца в клинике // Очерки клинической транс- плантологии / Под редакцией С.В. Готье. М., 2009. С. 285–324.; Шумаков В.И., Хубутия М.Ш., Белецкая Л.В. Оттор- жение гуморального типа при аллотрансплантации сердца. Тверь: Триада, 2003. 183 с.; Bradbery L.E., Kansas G.S., Levy S. et al. The CD19/ CD21 signal transducting complex of human B lympho- cytes includes the target of antiproliferative antibody-1 and Leu-13 molecules // J. Immunol. 1992. Vol. 149. P. 2841–2850.; Cogert G.A., Subherwal S., Wu G. et al. Incidence of non-cellular (humoral) rejection unchanged in the 1990 decade despite a decrease in cellular rejection // J. Heart Lung Transplant. 2003. Vol. 22. S. 119–142.; Dempsey P.W., Allison M.E.D., Akkaraju S. et al. C3d of complement as a molecular adjuvant: Bridging in- nate and acquired immunity // Science. 1996. Vol. 271. P. 348–350.; Dunn M.J., Crisp S.J., Rose M.L. et al. Antiendotheli- al antibodies and coronary artery disease after cardiac transplantation // Lancet. 1992. Vol. 339. P. 1566–1570.; Fishbein M.C., Kobashigawa J. Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy // Curr Opion Cardiol. 2004 Mar. Vol. 19 (2). P. 166–169.; Hammond E.H., Stehlik J., Snow G. Utility of Histologic Parameters in Screening for Antibody-Mediated Rejec- tion of Cardiac Allograft: A Study of 3170 Biopsies // J. Heart Lung Transplant. 2005. Vol. 24. P. 2015–2021.; Ibrahim M., Hendry P., Masters R. et al. Management of acute severe perioperative failure of cardiac allografts: a single-centre experience with a review of the literature // Can. J. Cardiol. 2007, April. Vol. 23 (5). P. 363–367.; Lee C-Y., Reynolds M., Garyu G., Baldwin W.M.III. et al. The involvement of FcR mechanisms in antiody-media- ted rejection // Transplantation. 2007. Vol. 84. P. 1324– 1334.; Leech S.H., Rubin S., Eisen H.J. et al. Cardiac transplan- tation across a positive prospective lymphocyte cross- match in sensitized recipients // Clin. Transplant. 2003. Vol. 17 (Suppl. 9). P. 17–26.; Matsumoto A.K., Kopicky-Burd J., Carter R.H. et al. Intersection of the complement and immune sistems: a signal transduction complex of the B lymphocytecontai- ning complement receptor // J. Exp. Med. 1991; Jan 1. Vol. 173 (1). P. 55–64.; Michaels P.J., Espejo M.L., Kobashigawa J. et al. Hu- moral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to trans- plant coronary artery disease // J. Heart Lung Transplant. 2003; Jan. Vol. 22 (1). P. 58–69.; Minami K., Murata K., Lee C-Y. et al. C4d deposition and clearance in cardiac transplants correlates with allo- antibody levels and rejection in rats // Am. J. Transplant. 2006. Vol. 6 (5). P. 923–932.; Morgun A., Shulzhenko N., Unterkircher C.S. et al. Pre- and post-transplant anti-myosin and anti-heart shock protein antibodies and cardiac transplantation out- come // J. Heart Lung Transplant. 2004; Feb. Vol. 23 (2). P. 204–209.; Murata K., Baldwin W.M.III. Mechanisms of comple- ment activation, C4d deposition, and their contribu- tion to the pathogenesis of antibody mediated rejec- tion // Transplant Rev (Orlando). 2009 July. Vol. 23 (3). P. 139–150.; Nath D.S., Basha H.I., Tiriveedhi V. et al. Characteriza- tion of immune responses to cardiac self-antigens myo- sin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy // J. Heart Lung Transplant. 2010, Nov. Vol. 29 (11). P. 1277–1285.; Patel N.D., Weiss E.S., Cameron D.E., Vricella L.A. ABO-incompatible heart transplantation in infants: ana- lysis of the united network for organ sharing databa- se // J. Heart Lung Transplant. 2008, Oct. Vol. 27 (10). P. 1085–1089.; Tambur A.R., Bray R.A., Takemoto S.K. et al. Flow cyto- metric detection of HLA-specific antibodies as a predic- tor of heart allograft rejection // Transplantation. 2000. Vol. 70. P. 1055–1059.; Tan C.D., Sokos G.G., Pidwell D.J. et al. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated re- jection // Am. J. Transplant. 2009. Vol. 9 (9). P. 2075– 2084.; Taylor D.O., Yowell R.L., Kfoury A.G. et al. Allograft coronary artery disease: clinical correlations with circu- lating anti-HLA antibodies and the immunohistopatholo- gic pattern of vascular rejection // J. Heart Lung Trans- plant. 2000. Vol. 19. P. 518–521.; Rodriguez E.R., Skojec D.V., Tan C.D. et al. Antibody- mediated rejection in human cardiac allografts: Evalu- ation of immunoglobulins and complement activation products C4d and C3d as markers // Am. J. Transplant. 2005. Vol. 5. P. 2778–2785.; Rose M.L., Cooper D.K., Human P.A. et al. Histopatho- logy of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts // J. Heart Lung Transplant. 1991, Mar-Apr. Vol. 10 (2). P. 223–234.; Warraich R.S., Pomerance A., Stanley A. et al. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopa- thy // Transplantation. 2000. Vol. 69. P. 1609–1617.; Wehner J.R., Morrell C.N., Rodriguez E.R. et al. Immu- nological Challenges of Cardiac Transplantation: the need for better animal models to answer current clinical questions // J. Clin. Immunol. 2009, Nov. Vol. 29 (6). P. 722–729.; https://journal.transpl.ru/vtio/article/view/377